Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Zeller

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Ebiomedicine|October 10, 2024
SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccinationIsabell Wagenhäuser, Kerstin Knies, Tamara Pscheidl, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Brain : a Journal of Neurology|December 30, 2025
Cross-species lesion mapping links a midbrain circuit to vergence dysfunctionMaximilian U Friedrich, Anja K E Horn, Helen Friedrich, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Brain Sciences|July 2, 2021
Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers' LivesPavel Schischlevskij, Isabell Cordts, René Günther, et al.
Brain Sciences|April 3, 2021
A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in GermanyTara Peseschkian, Isabell Cordts, René Günther, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS familiesKathrin Müller, David Brenner, Patrick Weydt, et al.
Journal of Neurology|June 25, 2023
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in GermanyFelix Heinrich, Isabell Cordts, René Günther, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Ebiomedicine|October 10, 2024
SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccinationIsabell Wagenhäuser, Kerstin Knies, Tamara Pscheidl, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Brain : a Journal of Neurology|December 30, 2025
Cross-species lesion mapping links a midbrain circuit to vergence dysfunctionMaximilian U Friedrich, Anja K E Horn, Helen Friedrich, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Brain Sciences|July 2, 2021
Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers' LivesPavel Schischlevskij, Isabell Cordts, René Günther, et al.
Brain Sciences|April 3, 2021
A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in GermanyTara Peseschkian, Isabell Cordts, René Günther, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS familiesKathrin Müller, David Brenner, Patrick Weydt, et al.
Journal of Neurology|June 25, 2023
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in GermanyFelix Heinrich, Isabell Cordts, René Günther, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, et al.
Pageof 7